Live AusBiotech updates | Page 2

Live AusBiotech news coverage of developments with the latest updates. Stay on top of latest AusBiotech news stories and find out what just happened, what is going on with AusBiotech. The latest real-time news updates and headlines on AusBiotech
Cochlear Boosts Earnings Forecast Amid Surging Implant Revenue
First AML Patient Treated in Chimeric's CHM 0201 Trial
Contest Begins for Boosting Early-Stage MedTech Pitches
Deflexifol Clinical Data Revealed at ASCO GI Cancer Symposium
AusBiotech Seeks Sustainable Funding for National Clinical Trials Hub
Cell & Gene Catalyst working groups members announced
Arovella Acquires License for New CARiNKT Cell Armouring Tech
Viraleze Proves Effective Against Covid, Reports Starpharma
2024 Australian of Year: Pioneering Melanoma Researchers
AusBiotech Members Summoned for Capital Attraction Roundtable
Aravax Secures Funds to Fast-Track Peanut Allergy Therapy
AVITA Medical, Stedical Scientific Ink US Distribution Deal
Chimeric Therapeutics Fulfills Placement, Secures Shortfall Commitments
Opthea Secures More Cash in Development Funding Deal
AusBiotech's Carina Begins LGR5-Targeted CAR-T Therapy Trial
Neuren Pharma Reveals Phase 2 NNZ-2591 Trial Top-Line Results
Year of collective success: 2023 in review
AusBiotech announces Acting CEO
CMAX Clinical Research Marks 30 Years of Continuous Operations
Brooker Consulting Debuts Twin Initiatives for Life Science Sector
FDA Fast-Tracks EnGeneIC's Pancreatic Cancer Drug
AusBiotech calls for journal articles 14 December
Prescient Reveals PTX-100 Phase 1b Study Results in T-Cell Lymphoma
New leadership for Health Security Systems Australia
Victorian Govt Supports Cyban's Brain Injury Tech Development
AusBiotech 2023: Australia's Clinical Trial Sector Unites
AusBiotech energised by new Board appointments
Turkey Approves Cynata Therapeutics' Phase 2 Trial
Microba Life Sciences Reveals Successful Phase IBD Trial Results
Telix Doses First Patient in European TLX250-CDx Trial
Neuren Completes Enrolment in Phase 2 Pitt Hopkins Trial
Aus Cell and Gene Catalyst Seeks Expressions of Interest
Korean Regulator Greenlights Amplia's Pancreatic Cancer Trial
First Patient Enrolled in OncoSil Medical's PANCOSIL Trial
Clarity Advances Prostate Cancer Trial at Highest Dose Level
Microba Concludes Stage One Screening for Autoimmune Program
AusBiotech Releases National Reconstruction Fund Investment Mandate
Govt Funds Development of Childhood Brain Cancer Treatment
New Industry Growth Program Prioritizes Medical Science
China Approves Dimerix's ACTION3 Investigational New Drug
AusBiotech weighs in on Australia's RNA future
AusBiotech Urges Change in Cell, Gene Catalyst Submission Scope
Alterity Therapeutics Secures $4.8M in Fresh Placement
Orthocell Reports Successful Tennis Elbow Cell Therapy Study
Anteris Announces Positive 30-Day Trial Haemodynamic Results
Biotech headed to Hill for AusBiotech's Policy Forum
Alterity Therapeutics Unveils Fresh ATH434 Data
US FDA Awards Orphan Drug Status to Argenica's ARG-007